Brief: Akari Therapeutics Appoints Rachelle Jacques As CEO And President

Akari Therapeutics

02/03/2022 12:24

March 2 (Reuters) - Akari Therapeutics PLC  AKTX.O :
    * AKARI THERAPEUTICS APPOINTS RACHELLE JACQUES AS PRESIDENT
AND
CHIEF EXECUTIVE OFFICER
    * AKARI THERAPEUTICS PLC -  JACQUES APPOINTMENT BEGINS AT
END OF
MARCH 2022
    * AKARI THERAPEUTICS PLC - JACQUES WILL ALSO JOIN CO'S BOARD
    * AKARI THERAPEUTICS PLC - OUTGOING CEO, CLIVE RICHARDSON,
WILL
CONTINUE TO SERVE CO, ENSURING SMOOTH TRANSITION

Source text for Eikon:  ID:nGNX80lf28 
Further company coverage:  AKTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))